The content that appears on this page is presented as an overview vs. comparative marketing. The provided information includes product information, overviews, buying guides, and product specifications. All trademarks, registered trademarks and service-marks mentioned on this site are the property of their respective owners. If something is factually inaccurate please contact us and let us know. By contributing your product facts helps to better serve our readers and the accuracy of the content.
The table below does not include all companies or all available products in the market but those that we promote as their affiliates. In full compliance with the FTC guidelines, please assume that any and all links on the table are affiliate links, and we may receive compensation if you click one of these and make a purchase. We are independently owned and the opinions expressed here are our own. All editorial content is written without prejudice or bias, regardless of sponsor or affiliate associations.
Belviq (lorcaserin) is the “freshest” prescription diet pill that has been approved by the United States Food and Drug Administration (FDA) in 13 long years! The million dollar question here is— why now?
You probably know that weight loss supplements have been associated with vicious side effects, such as increased risk of heart problems and liver failure. In fact the last weight loss drug approved by the FDA is Xenical (Orlistat), which is also considered the safest.
Apart from curbing the appetite and hunger pangs, Serotonin is also connected to mood and most antidepressants prevent the reuptake of serotonin, which also keeps the brain saturated with the chemical. Then again, Arena Pharmaceuticals researchers state that their drug only affects serotonin receptors that influence appetite.
The clinical trial reported by Arena Pharmaceuticals to the FDA indicates that almost half of the subjects who used Belviq and do not suffer from Type 2 diabetes lost at least 5% of their initial weight. This sums to an average of 12 pounds after 12 weeks of use.
For optimal results, the manufacturer advises dieters to combine a healthy diet and regular exercise while using Belviq. The drug is taken twice a day and is approved by the FDA for obese adults with a body mass index (BMI) of at least 30.
FDA says even overweight people having a BMI of 27 and up and suffering from one of weight-induced ailments such as hypertension, high cholesterol or Type 2 diabetes can use Belviq may use Belviq.
Belviq: Positive Features
Talking about safety belviq pills has undergone many tests hence it is safe to take, but we still advice you to visit your doctor before taking the pills.
Belviq: Negative Features
It as such has no side effects but still may react to some body type. Hence consult your doctor before taking the pills.
Belviq: Bottom Line
Obesity is a growing problem and the United States that is why drugs like Belviq are in high demand. Belviq works by suppressing the appetite through the activation of brain receptors for serotonin, triggering the feeling of satiety. Simply put, you’ll feel full and satisfied faster, thus less food is consumed.
**This is a subjective assessment based on the strength of the available information and our estimation of efficacy.
*Result may vary. If you have a serious medical condition, or have a history of heart conditions we suggest consulting with a physician before using any supplement. The information contained in this website is provided for general informational purpose only. It is not intended to diagnose, treat, cure or prevent any disease and should not be relied upon as a medical advice. Always consult your doctor before using any supplements.
*Disclosure of Material connection: Some of the links in the post above are “associate sales links.” This means if you can click on the link and purchase an item, we will receive a commission. Regardless, we only recommend products or services which we use personally and/or believe will add value to our readers. We are disclosing this in accordance with the Federal Trade Commission's 16 CFR, Part 255: “Guides Concerning the Use of Endorsements and Testimonials.”